An Amgen spokesperson said it "takes scientific integrity seriously and respects the role of journals in upholding the peer review process."

NEJM retracts pivotal data behind Amgen's Tavneos after FDA probe finds results for 9 patients re-evaluated post-unblinding; EU also moves to revoke.

An Amgen spokesperson said it "takes scientific integrity seriously and respects the role of journals in upholding the peer review process."

Move follows actions 'inconsistent with proper research conduct,' journal says